about
Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutationsHCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and functionTargeted disruption of the Cl-/HCO3- exchanger Ae2 results in osteopetrosis in miceFriend or foe: high bone mineral density on routine bone density scanning, a review of causes and managementRole of Ostm1 Cytosolic Complex with Kinesin 5B in Intracellular Dispersion and Trafficking.Disorders of bone remodelingSynaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretionMutational analysis of sclerostin shows importance of the flexible loop and the cystine-knot for Wnt-signaling inhibitionRegulation of osteoclast differentiationDissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strengthNFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.Current themes in molecular pediatrics: molecular medicine and its applications.Late-onset Visual Loss in Osteopetrosis.Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice.A deletion mutation in bovine SLC4A2 is associated with osteopetrosis in Red Angus cattle.Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.Osteopetrosis with micro-lacunar resorption because of defective integrin organizationImpaired vibration of auditory ossicles in osteopetrotic miceTranscriptional regulation of bone and joint remodeling by NFATOsteoclasts and odontoclasts: signaling pathways to development and disease.Case 1: An 18-month-old female infant with pancytopenia and hepatosplenomegaly.The actin binding protein adseverin regulates osteoclastogenesisHematopoietic stem cell transplantation for infantile osteopetrosis.Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis.Osteoclasts; culprits in inflammatory osteolysis.Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.NF-κB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation.Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.Flemingia macrophylla Extract Ameliorates Experimental Osteoporosis in Ovariectomized RatsRole of RANKL-RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications.Dysosteosclerosis presents as an "osteoclast-poor" form of osteopetrosis: comprehensive investigation of a 3-year-old girl and literature review.SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion.HDAC9 Inhibits Osteoclastogenesis via Mutual Suppression of PPARγ/RANKL Signaling.Rac deletion in osteoclasts causes severe osteopetrosisOsteopetrosis: A New Cause of Upper Gastrointestinal Bleeding.RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutationsPycnogenol(®) treatment inhibits bone mineral density loss and trabecular deterioration in ovariectomized rats.Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene Therapy.Potential role of odanacatib in the treatment of osteoporosis.
P2860
Q24310432-4BBA589F-BBA9-4E57-BC60-81B05095F246Q24644323-1790234D-A338-4DA2-BEE7-084EA14737CBQ24658114-BEA9B081-987F-4BFC-BCED-FA46C1486232Q27025982-1021B175-B930-43CA-BD83-AE6AA9AD72EBQ27320758-32C864DA-92B7-466F-BE1F-D454C0343459Q28295303-463834E5-8D1E-4168-AF33-90082EF9CF46Q28512093-E0C48F7B-DE93-4722-8D3A-80896A0609ADQ28535490-8762D1C3-062B-4400-ABB5-8A3845882E20Q28593319-1910E4A3-FCE0-48FF-B296-39D1988DB0F8Q28743063-8D2B7740-EE3D-4BA5-90AA-670F99455E31Q30157499-A5A8719C-040C-43DD-819A-3A8D0ED9C3BBQ30397005-4FFFF307-1330-48EE-B132-BB7FCBC04173Q30472927-E18111DC-2BA7-441E-BABE-E32AA026B20FQ30827854-1B5935C4-877E-41C4-A4F5-935973AAD505Q33589534-0139542F-5EE4-4765-96BD-A95E32BA2600Q33718764-E04645CD-CE58-4528-A8C5-3D6F33FB1399Q33799330-FF084BB6-9D22-4782-B863-19924BE48182Q33831246-0E8C4B5B-4B2F-47A9-8AE3-823F6D6690E2Q33998768-ED832FBC-2B87-4915-9F89-67B0E316BFDFQ34127948-D409F83D-F097-4C9A-95A8-871BAF6A927AQ34238237-421E1907-C02C-49C1-A20F-B228660B4B3BQ34282310-ECFF8C60-ADAF-4F80-A434-EF6E129FEDFEQ34477968-B7C394E6-61EE-41C3-9448-DE962749339DQ34825981-D0CFF50B-92E8-4CDB-9D4B-849A66247AF4Q34896003-0D7361F6-D922-4CC0-9DF0-C79CE4BB4A4AQ34911875-90202751-AD68-47D5-8EFC-0A07EB530039Q34912673-F0DCDD94-78FF-4BAB-B42D-00E96897121EQ35040136-D8C0EA16-AE68-4703-BE26-439812889A20Q35067806-76A7A1C1-2BCD-451F-8D54-2A0695E5FC2BQ35108799-9FA8D0D7-1F71-44B8-B1D0-E82A525291B4Q35165886-6E3C66C5-7031-4DAD-B8EA-040DECCF661CQ35229848-AD7F63CB-103B-4EB0-941F-FEACF55B189CQ35555130-4E77ADC2-2322-4B1D-A8F8-7E2F7A2C72EEQ35555670-EA620050-2C63-40CF-9A42-EEB56AFE5149Q35576455-326EFA6C-0DC4-436B-890A-DF87E5EC17D3Q35618263-6A28E3CA-D404-4FD5-8D93-489A2D2892E1Q35837418-184E71AE-5BD6-4EA1-8C44-57925BB98602Q36046329-88127FF4-EFB9-4715-AF90-A64AB08152FDQ36107803-48F143BB-4E25-4C61-AD71-199E059D73BEQ36136239-2A43F53D-3982-4831-8ADB-BB66E9F184F2
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Osteopetrosis.
@ast
Osteopetrosis.
@en
Osteopetrosis.
@nl
type
label
Osteopetrosis.
@ast
Osteopetrosis.
@en
Osteopetrosis.
@nl
prefLabel
Osteopetrosis.
@ast
Osteopetrosis.
@en
Osteopetrosis.
@nl
P356
P1476
Osteopetrosis.
@en
P2093
Paul J Orchard
P304
P356
10.1056/NEJMRA040952
P407
P577
2004-12-01T00:00:00Z